Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Conray 60
2. Iotalamate Meglumine
3. Iotalamate, Meglumine
4. Iotalamate, Methylglucamine
5. Iothalamate, Meglumine
6. Iothalamate, Methylglucamine
7. Iothalamic Acid Meglumine
8. Iothalamic Acid Methylglucamine
9. Meglumine Iotalamate
10. Meglumine Iothalamate
11. Meglumine, Iotalamate
12. Meglumine, Iothalamate
13. Meglumine, Iothalamic Acid
14. Methylglucamine Iotalamate
15. Methylglucamine Iothalamate
16. Methylglucamine, Iothalamic Acid
1. 13087-53-1
2. Meglumine Iotalamate
3. Conray
4. Meglumine Iothalamate
5. Iotalamate Meglumine
6. Xuw72gop7w
7. Iothalamate Meglumine [usp]
8. Meglumine Iotalamate Injection
9. 1-deoxy-1-(methylamino)-d-glucitol 3-(acetylamino)-2,4,6-triiodo-5-[(methylamino)carbonyl]benzoate
10. 3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic Acid;(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol
11. 1-deoxy-1-(methylamino)-d-glucitol 5-acetamido-2,4,6-triiodo-n-methylisophthalamate (salt)
12. Iothalamate Meglumine (usp)
13. Conray 60
14. Conray Meglumin
15. Meglumine Conray
16. Methylglucamine Iotalamate
17. Cysto-conray
18. Methylglucamine Iothalamate
19. Cysto-conray Ii
20. 3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic Acid;6-(methylamino)hexane-1,2,3,4,5-pentol
21. Benzoic Acid, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)-, Compd. With 1-deoxy-1-(methylamino)-d-glucitol (1:1)
22. Contrix 28
23. Conray 30
24. Conray 43
25. Meglumine Isothalamate
26. Conray Meglumine 282
27. Iothalamate Methylglucamine
28. Iotalamate De Methylglucamine
29. Iothalamate Methylglucamine Salt
30. Jotalamsaeure Methylglucaminesalz
31. 1-deoxy-1-(methylamino)-d-glucitol 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate
32. Einecs 235-998-9
33. Conray (tn)
34. Iothalamic Acid N-methylgucamine Salt
35. Iotalamate De Methylglucamine [french]
36. Iotalamic Acid Meglumine
37. Jotalamsaeure Methylglucaminesalz [german]
38. Unii-xuw72gop7w
39. Meglumine Iothalamate [ban]
40. D-glucitol, 1-deoxy-1-(methylamino)-, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate (salt)
41. Meglumine Iotalamate (jp17)
42. Schembl180546
43. Chembl1201125
44. Chebi:31714
45. Dtxsid10926949
46. Iothalamate Meglumine [vandf]
47. Meglumine Iotalamate [mart.]
48. Iotalamate Meglumine [who-dd]
49. Isophthalamic Acid, 5-acetamido-2,4,6-triiodo-n-methyl-, Compd. With 1-deoxy-1-(methylamino)-d-glucitol (1:1)
50. Iothalamate Meglumine [orange Book]
51. Iothalamate Meglumine [usp Impurity]
52. D01999
53. Vascoray Component Iothalamate Meglumine
54. Iothalamate Meglumine Component Of Vascoray
55. Iothalamic Acid N-methylglucamine Salt [mi]
56. Q27294007
57. 5-acetamido-2,4,6-triiodo-n-methylisophthalamic Acid-methylglucamine
58. Benzoic Acid, 3-(acetylamino)-2,4,6-triiodo-5-[(methylamino)carbonyl]-, Compd. With D-glucitol, 1-deoxy-1-(methylamino)- (1:1)
| Molecular Weight | 809.1 g/mol |
|---|---|
| Molecular Formula | C18H26I3N3O9 |
| Hydrogen Bond Donor Count | 9 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 9 |
| Exact Mass | 808.8803 g/mol |
| Monoisotopic Mass | 808.8803 g/mol |
| Topological Polar Surface Area | 209 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 555 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 8 | |
|---|---|
| Drug Name | Conray 30 |
| Drug Label | Conray 30 is a sterile aqueous solution intended for use as a diagnostic radiopaque medium. Conray 30 contains 30% w/v iothalamate meglumine which is 1-deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6 triiodo-N-methylisophthalamate (salt), and has... |
| Active Ingredient | Iothalamate meglumine |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 30% |
| Market Status | Prescription |
| Company | Mallinckrodt |
| 2 of 8 | |
|---|---|
| Drug Name | Conray 43 |
| Drug Label | Conray 43 is a sterile aqueous solution intended for use as a diagnostic radiopaque medium. Conray 43 contains 43% w/v iothalamate meglumine which is 1-deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6-triiodo-N-methylisophthalamate (salt), and has... |
| Active Ingredient | Iothalamate meglumine |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 43% |
| Market Status | Prescription |
| Company | Mallinckrodt |
| 3 of 8 | |
|---|---|
| Drug Name | Cysto-conray |
| Drug Label | Cysto-Conray II is a sterile aqueous solution intended for instillation as a diagnostic radiopaque medium. Cysto-Conray II contains 17.2% w/v iothalamate meglumine which is 1-Deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6-triiodo-N-methylisophtha... |
| Active Ingredient | Iothalamate meglumine |
| Dosage Form | Solution |
| Route | intravesical, ureteral |
| Strength | 43% |
| Market Status | Prescription |
| Company | Mallinckrodt |
| 4 of 8 | |
|---|---|
| Drug Name | Cysto-conray ii |
| Drug Label | Cysto-Conray II is a sterile aqueous solution intended for instillation as a diagnostic radiopaque medium. Cysto-Conray II contains 17.2% w/v iothalamate meglumine which is 1-Deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6-triiodo-N-methylisophtha... |
| Active Ingredient | Iothalamate meglumine |
| Dosage Form | Solution |
| Route | Intravesical |
| Strength | 17.2% |
| Market Status | Prescription |
| Company | Mallinckrodt |
| 5 of 8 | |
|---|---|
| Drug Name | Conray 30 |
| Drug Label | Conray 30 is a sterile aqueous solution intended for use as a diagnostic radiopaque medium. Conray 30 contains 30% w/v iothalamate meglumine which is 1-deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6 triiodo-N-methylisophthalamate (salt), and has... |
| Active Ingredient | Iothalamate meglumine |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 30% |
| Market Status | Prescription |
| Company | Mallinckrodt |
| 6 of 8 | |
|---|---|
| Drug Name | Conray 43 |
| Drug Label | Conray 43 is a sterile aqueous solution intended for use as a diagnostic radiopaque medium. Conray 43 contains 43% w/v iothalamate meglumine which is 1-deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6-triiodo-N-methylisophthalamate (salt), and has... |
| Active Ingredient | Iothalamate meglumine |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 43% |
| Market Status | Prescription |
| Company | Mallinckrodt |
| 7 of 8 | |
|---|---|
| Drug Name | Cysto-conray |
| Drug Label | Cysto-Conray II is a sterile aqueous solution intended for instillation as a diagnostic radiopaque medium. Cysto-Conray II contains 17.2% w/v iothalamate meglumine which is 1-Deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6-triiodo-N-methylisophtha... |
| Active Ingredient | Iothalamate meglumine |
| Dosage Form | Solution |
| Route | intravesical, ureteral |
| Strength | 43% |
| Market Status | Prescription |
| Company | Mallinckrodt |
| 8 of 8 | |
|---|---|
| Drug Name | Cysto-conray ii |
| Drug Label | Cysto-Conray II is a sterile aqueous solution intended for instillation as a diagnostic radiopaque medium. Cysto-Conray II contains 17.2% w/v iothalamate meglumine which is 1-Deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6-triiodo-N-methylisophtha... |
| Active Ingredient | Iothalamate meglumine |
| Dosage Form | Solution |
| Route | Intravesical |
| Strength | 17.2% |
| Market Status | Prescription |
| Company | Mallinckrodt |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - 43%
USFDA APPLICATION NUMBER - 13295
DOSAGE - INJECTABLE;INJECTION - 60%
USFDA APPLICATION NUMBER - 13295
DOSAGE - INJECTABLE;INJECTION - 30%
USFDA APPLICATION NUMBER - 16983
Digital Content
DATA COMPILATION #PharmaFlow
ABOUT THIS PAGE
99
PharmaCompass offers a list of Iothalamate Meglumine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Iothalamate Meglumine manufacturer or Iothalamate Meglumine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Iothalamate Meglumine manufacturer or Iothalamate Meglumine supplier.
PharmaCompass also assists you with knowing the Iothalamate Meglumine API Price utilized in the formulation of products. Iothalamate Meglumine API Price is not always fixed or binding as the Iothalamate Meglumine Price is obtained through a variety of data sources. The Iothalamate Meglumine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Conray 60 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Conray 60, including repackagers and relabelers. The FDA regulates Conray 60 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Conray 60 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Conray 60 supplier is an individual or a company that provides Conray 60 active pharmaceutical ingredient (API) or Conray 60 finished formulations upon request. The Conray 60 suppliers may include Conray 60 API manufacturers, exporters, distributors and traders.
Conray 60 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Conray 60 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Conray 60 GMP manufacturer or Conray 60 GMP API supplier for your needs.
A Conray 60 CoA (Certificate of Analysis) is a formal document that attests to Conray 60's compliance with Conray 60 specifications and serves as a tool for batch-level quality control.
Conray 60 CoA mostly includes findings from lab analyses of a specific batch. For each Conray 60 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Conray 60 may be tested according to a variety of international standards, such as European Pharmacopoeia (Conray 60 EP), Conray 60 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Conray 60 USP).
